20Slash20 Inc., the company behind The Eye Drink, a ready-to-drink functional beverage formulated to support eye health, announced its participation in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference. The event will take place on Sept. 9–10, 2026, at The Westin New York Grand Central in New York City. CEO Dr. Roger Wu is scheduled to deliver an investor presentation at 9:35 a.m. ET on Sept. 9 and will hold one-on-one meetings with investors.
The conference brings together growth companies, investors, and industry professionals across life sciences and other emerging sectors, providing a platform for 20Slash20 to showcase its unique product to a targeted audience. The Eye Drink is positioned as the world's first ready-to-drink functional beverage specifically designed for individuals who spend extended hours on digital devices, addressing the growing concern of screen-induced eye problems.
The significance of this presentation lies in the increasing prevalence of digital eye strain. With millions of people worldwide relying on smartphones and computers for work and leisure, the demand for convenient, science-backed solutions is on the rise. 20Slash20 aims to capitalize on this trend by offering a tasty and portable option that supports eye health.
The company's participation in this conference underscores its commitment to growth and innovation in the functional beverage market. By engaging with investors and industry leaders at this event, 20Slash20 seeks to raise awareness about its product and potentially secure funding or partnerships to accelerate its market penetration.
According to the press release, The Eye Drink contains science-backed ingredients that are believed to help protect eyes from the harmful effects of prolonged screen exposure. This includes ingredients known for their antioxidant properties and those that support retinal health.
The conference presents an opportunity for 20Slash20 to differentiate itself in a crowded beverage market. While functional beverages are popular, few target eye health specifically. This niche positioning could be a key differentiator for the company.
For more information about the conference or to view the full press release, visit https://ibn.fm/tm2lT.
About 20Slash20 Inc.: The company has created The Eye Drink, a ready-to-drink functional beverage formulated with science-backed ingredients for individuals who spend extended hours on cellphones or computers, aiming to protect their eyes from screen-induced problems. It offers a convenient and tasty solution to support eye health in today's screen-centric world.
About InvestorWire: InvestorWire is a specialized communications platform focused on advanced wire-grade press release syndication for private and public companies and the investment community. It is part of the Dynamic Brand Portfolio @IBN, which provides access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and tailored corporate communications solutions. For more information, visit https://www.InvestorWire.com.
